| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000012859 |
| Receipt No. | R000015010 |
| Official scientific title of the study | Total laparoscopic sacrocolpopexy for patients with pelvic organ prolapse |
| Date of disclosure of the study information | 2014/01/15 |
| Last modified on | 2017/07/19 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Total laparoscopic sacrocolpopexy for patients with pelvic organ prolapse | |
| Title of the study (Brief title) | Total laparoscopic sacrocolpopexy for patients with pelvic organ prolapse | |
| Region |
|
|
| Condition | ||
| Condition | pelvic organ prolapse | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We test the safety and efficacy of laparoscopic sacrocolpopexy for patients with pelvic organ prolapse. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Improvement of POP-Q staging, amount of hemorrhage during the procedure |
| Key secondary outcomes | presence of intra- and post-surgical complications, Values of hemoglobin, whtie blood cell count and CRP, Duration and extent of fever, |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | We evaluate the efficacy and safety of laparoscopic sacrocolpopexy for patients with pelvic organ prolapse. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patients possessing pelvic organ prolapse (
more than stage III of POP-Q stage) are included in this study and their age should be less than 80. They should be without life-threatning complications and hope this surgery. Uteri should be smaller than new-born infant and can be managed by laparoscopy. It should be demanded to obtain written informed consent. |
|||
| Key exclusion criteria | Patients possessing adhesion around the uterus and having difficulties to perform the designed operation.
Those who can not understand the meaning and explanation of this surgery. Other patients that are supposed to be inadequate to enroll this study. |
|||
| Target sample size | 5 | |||
| Research contact person | |
| Name of lead principal investigator | Osamu Hiraike |
| Organization | The University of Tokyo |
| Division name | Obstetrics and Gynecology |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo |
| TEL | 03-3815-5411 |
| wada-gyn@h.u-tokyo.ac.jp | |
| Public contact | |
| Name of contact person | Osamu Hiraike |
| Organization | The University of Tokyo |
| Division name | Obstetrics and Gynecology |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo |
| TEL | 03-3815-5411 |
| Homepage URL | |
| wada-gyn@h.u-tokyo.ac.jp | |
| Sponsor | |
| Institute | The University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The University of Tokyo |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015010 |